News Releases

Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the DxI 9000 Immunoassay Analyzer* was honored during Premier, Inc.'s annual supplier Innovation Celebration at its...

Ideally Suited for Satellite and Independent Labs, the new DxC 500i Analyzer Offers Flexibility, Scalability and Data Commutability with Extensive Chemistry and Immunoassay Assay Menu The New DxC...

New Access NT-proBNP Assay Detects Heart Failure Biomarker in Less than 11 Minutes Patient Results Evaluated Within Context of Clinically Relevant Age-Based Cutoffs, Disease Comorbidity Data and...

Beckman Coulter Now an Authorized Distributor of MeMed Key Immunoassay System and MeMed BV Assay Progress Continues on Original Collaboration to Develop a MeMed BV-Based Assay for use on Beckman...

Beckman Coulter Diagnostics, a leader in clinical diagnostics, announced today, ahead of the congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global), that...

Beckman Coulter Diagnostics, a clinical diagnostics leader, and Fujirebio, a leader in neurological markers and In Vitro Diagnostic (IVD) manufacturing, today announced an expansion of their...

Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced Kevin O'Reilly's appointment as its new president succeeding Julie Sawyer Montgomery, who is now vice president and...

New analyzer complements hub labs by advancing capabilities of satellite and independent community hospital labs DUBAI , UAE, Jan. 29, 2024 /PRNewswire/ -- Beckman Coulter Diagnostics, a clinical...

Beckman Coulter, a clinical diagnostics leader, today revealed for the first time in North America the DxI 9000 Access Immunoassay Analyzer, addressing clinical laboratory demands for speed,...

Beckman Coulter Diagnostics, a clinical diagnostics leader, received FDA clearance for its new DxC 500 AU Chemistry Analyzer, an automated chemistry analyzer, expanding the company's clinical...